News and presentations

An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM). For cervical cancer, 94% of deaths occur in low- and middle-income countries (350,000 women died in 2022). Ra ...

ARCHERY CI Ajay Aggarwal recently appeared on the Simply Oncology podcast to discuss AI radiotherapy planning and the ARCHERY trial:  "Join us as we tackle the topic of Artificial intelligence in Radiotherapy. This week we speak to the excellent Professor Ajay Aggarwal about the use of AI in radiotherapy planning. We discuss the international ARCHERY trial using an ...

The ARCHERY team are pleased to confirm the study has surpassed it's recruitment target of 990 participants (330 per tumour type)! Since recruiting the first participant in December 2023, our sites in India, Jordan, Malaysia and South Africa have worked hard to meet these targets and you can read more about the teams involved on our centres pages here.  You can see the progres ...

Archery is funded by Rising Tide and NIH